Delta Secretase and BDNF Signalling in Alzheimer's Disease

被引:0
|
作者
Unlu, Buse [1 ]
Ildiz, Sumeyra [1 ]
Ak, Duygu Gezen [1 ]
Dursun, Erdinc [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Inst Neurol Sci, Dept Neurosci, Istanbul, Turkiye
来源
EXPERIMED | 2023年 / 13卷 / 01期
关键词
BDNF; axonal transport; delta secretase; Alzheimer's disease; APP; tau protein; AXONAL-TRANSPORT; TAU; PHOSPHORYLATION; RECEPTORS; CLEAVAGE; LEGUMAIN; BETA;
D O I
10.26650/experimed.1231893
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
As one of the major contributors of the central nervous system, neurons require neurotrophic factors, which are synthesized from neighbouring cells, for several cellular processes, such as neuronal survival, growth, and differentiation. Neurotrophic factors are categorized into the neurotrophin family, the neuropoietic cytokines, and the glial cell-derived neurotrophic factor. The neurotrophin family comprises four growth factors: nerve growth factor (NGF), neurotrophin-3 (NT3), neurotrophin-4 (NT4), and brain-derived neurotrophic factor (BDNF). One of the best-known neurotrophic factors is BDNF. Its importance is based on its central role in neuronal survival. Entry of the BDNF into the neurons occurs via TrkB receptors, and it is transported to the cell body along microtubules in axons. As it is known in the brains of Alzheimer's patients, the axonal transport of BDNF is destructed via the hyperphosphorylated tau. There are several causes for the hyperphosphorylation of tau. Among them, delta secretase (delta-secretase), a lysosomal cysteine protease, cleaves both amyloid precursor protein (APP) and tau. It is supposed to play an essential role in tau hyperphosphorylation, particularly in the aging brain. In this review, we focus on the activity of delta-secretase, how it leads to tau hyperphosphorylation, and how it disrupts the axonal transport of BDNF in Alzheimer's disease.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] Regulation of γ-secretase activity in Alzheimer's disease
    Zhou, Shuxia
    Zhou, Hua
    Walian, Peter J.
    Jap, Bing K.
    BIOCHEMISTRY, 2007, 46 (10) : 2553 - 2563
  • [32] γ-Secretase as a Therapeutic Target in Alzheimer's Disease
    Guardia-Laguarta, C.
    Pera, M.
    Lleo, A.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 506 - 517
  • [33] Amyloid β, γ-secretase, and familial Alzheimer's disease
    Potier, Marie-Claude
    Steiner, Harald
    Chavez-Gutierrez, Lucia
    LANCET NEUROLOGY, 2024, 23 (09): : 852 - 853
  • [34] gamma-Secretase in Alzheimer's disease
    Hur, Ji-Yeun
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (04): : 433 - 446
  • [35] The role of BDNF in Alzheimer's disease
    Tanila, Heikki
    NEUROBIOLOGY OF DISEASE, 2017, 97 : 114 - 118
  • [36] β-secretase as a therapeutic target for Alzheimer's disease
    Ghosh, Arun K.
    Gemma, Sandra
    Tang, Jordan
    NEUROTHERAPEUTICS, 2008, 5 (03) : 399 - 408
  • [37] Therapeutic potential of α-secretase in Alzheimer's disease
    Yang, HQ
    Chen, SD
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2006, 33 (02) : 109 - 115
  • [38] β-Secretase as a therapeutic target for Alzheimer’s disease
    Arun K. Ghosh
    Sandra Gemma
    Jordan Tang
    Neurotherapeutics, 2008, 5 : 399 - 408
  • [39] Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase
    Kang, Seong Su
    Wu, Zhourui
    Liu, Xia
    Edgington-Mitchell, Laura
    Ye, Keqiang
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1283 - 1297
  • [40] Treating Parkinson’s Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase
    Seong Su Kang
    Zhourui Wu
    Xia Liu
    Laura Edgington-Mitchell
    Keqiang Ye
    Neurotherapeutics, 2022, 19 : 1283 - 1297